Data / Medical devices / Canada / Sekisui Diagnostics P.E.I. Inc.
Sekisui Diagnostics P.E.I. Inc.: FDA-registered device maker in CHARLOTTETOWN Prince Edward Island, Canada, 52 510(k) clearances
Sekisui Diagnostics P.E.I. Inc. is registered with the FDA (registration 8020316) in CHARLOTTETOWN Prince Edward Island, Canada. It lists 47 device types. The FDA files 52 510(k) clearances under its listings, the newest dated February 18, 2022. 7 recall events name it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 8020316
- FEI number
- 3002806809
- Address
- 70 Watts Avenue, CHARLOTTETOWN Prince Edward Island, Canada, C1E 2B9
- Owner or operator
- Sekisui Diagnostics, LLC (10035388)
- Roles
- Contract manufacturer, Exporter to the US, Manufacturer, Repackager or relabeler
- First device listed
- February 24, 2011
- Registered through
- 2026
- Brand names listed
- ALT-SL, Acetaminophen, Acetaminophen Assay, Acetaminophen Cal, Acetaminophen L3K, Acetaminophen L3K Assay, Acetaminophen SL, Alanine Amino Transferase L3K and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| February 18, 2022 | K202644 | Acetaminophen | LDP | Substantially Equivalent | Sekisui Diagnostics P.E.I., Inc. | accessdata.fda.gov |
| February 8, 2019 | K180835 | SEKURE Acetaminophen L3K Assay | LDP | Substantially Equivalent | Sekisui Diagnostics P.E.I., Inc. | accessdata.fda.gov |
| December 8, 2016 | K163078 | DC-UIBC-CAL | JIT | Substantially Equivalent | Sekisui Diagnostics P.E.I., Inc. | accessdata.fda.gov |
| December 2, 2011 | K111915 | MAGNESIUM ASSAY | JGJ | Substantially Equivalent | Sekisui Diagnostics P.E.I., Inc. | accessdata.fda.gov |
| May 1, 2009 | K081938 | ACETAMINOPHEN L3K ASSAY, AND ACETAMINOPHEN L3K ASSAY, MODELS 506-10, 506-30 | LDP | Substantially Equivalent | Genzyme Diagnostics P.E.I., Inc. | accessdata.fda.gov |
| June 22, 2007 | K070383 | ENZYMATIC CREATININE ASSAY (265 SERIES) | JFY | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| January 19, 2007 | K063208 | MAGNESIUM ASSAY (XB), MODELS 125-12, 125-50 AND 125-S7 | JGJ | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| July 5, 2005 | K051191 | DCL MICROALBUMIN ASSAY, MODEL 252-20 | DCF | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| January 7, 2005 | K042330 | ACETAMINOPHEN-SL ASSAY | LDP | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| December 27, 2004 | K042362 | MODIFICATION TO CARBON DIOXIDE-L3K ASSAY, CAT. NOS. 299-30, 299-17, 299-50, 299-80 AND 299-12 | KHS | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| December 27, 2004 | K042329 | SALICYLATE-SL ASSAY | DKJ | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| October 4, 2004 | K042243 | MICROALBUMIN MULTI-CALIBRATOR SET | JIX | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| March 10, 2004 | K033921 | AMMONIA-L3K ASSAY, CATALOGUE NUMBER 233-10 | JIF | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| June 2, 2003 | K030546 | CRP (II) CALIBRATORS | JIS | Substantially Equivalent | Denka Seiken Co., Ltd. | accessdata.fda.gov |
| June 2, 2003 | K030545 | CRP-LATEX (II)X2 SEIKEN ASSAY KIT | DCK | Substantially Equivalent | Denka Seiken Co., Ltd. | accessdata.fda.gov |
| January 17, 2003 | K023739 | GLUCOSE-SL-C ASSAY, MODEL 257-30 | CFR | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| December 11, 2002 | K023330 | BILIRUBIN-SL (TOTAL) ASSAY, MODEL 284-10/30 | CIG | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| July 25, 2002 | K021316 | ULTRA N-GENEOUS HDL CHOLESTEROL REAGENT 1/REAGENT2; ULTRA N-GENEOUS HDL CHOLESTREOL CALIBRATOR | LBS | Substantially Equivalent | Genzyme Corp. | accessdata.fda.gov |
| May 14, 2002 | K020816 | IRON-PC-SL ASSAY MODEL # 151-10, 151-26 | JIY | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| August 10, 2001 | K011843 | GENZYME DIRECT-AMYLASE TEST REAGENT | JFJ | Substantially Equivalent | Genzyme Corp. | accessdata.fda.gov |
| November 27, 2000 | K003093 | ALKALINE PHOSPHATASE-SL ASSAY, MODELS 328-17 AND 328-30 | CJE | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| September 26, 2000 | K002354 | CARBON DIOXIDE-L3K-C ASSAY, MODELS 288-30 AND 288-80 | KHS | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| September 15, 2000 | K002694 | UREA-L3K ASSAY, CATALOGUE NUMBER 283-17/30 | CDQ | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| June 20, 2000 | K001286 | ETHANOL-L3K ASSAY, MODELS 273-30, 273-17, 273-10 | DIC | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| February 18, 2000 | K000055 | CREATININE-S ASSAY, MODEL 221-30, 221-50, 221-17 | CGX | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| October 18, 1999 | K992766 | N-GENEOUS LDL-ST CHOLESTEROL REAGENT, N-GENEOUS LDL-ST CHOLESTEROL CALIBRATOR, GENZYME LDL CHOLESTEROL CONTROL SET | MRR | Substantially Equivalent | Genzyme Corp. | accessdata.fda.gov |
| June 3, 1998 | K981609 | BILIRUBIN-SL (DIRECT) ASSAY CATALOGUE NUMBER 247-10,247-30 | CIG | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| March 11, 1998 | K973999 | CREATINE KINASE-SL ASSAY, CATALOGUE NUMBER 326-10, 326-30 | CGS | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| February 12, 1998 | K974874 | BILIRUBIN-SL (TOTAL) ASSAY | CIG | Substantially Equivalent | Diagnostic Chemicals, Ltd. (Usa) | accessdata.fda.gov |
| January 30, 1998 | K974858 | PHOSPHORUS-SL ASSAY, CATALOGUE NUMBER 117-10, 117-30 | CEO | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| December 5, 1997 | K974003 | ALANINE AMINOTRANSFERASE-SL ASSAY CATALOGUE NUMBER 318-10, 318-30 | CKA | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| November 13, 1997 | K974001 | ASPARTATE AMINOTRANSFERASE-SL ASSAY, CATALOGUE NUMBER 319-10, 319-30 | CIT | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| November 4, 1997 | K974000 | Y-GLUTAMYLTRANSFERASE-SL ASSAY , CATALOGE NUMBER 324-10, 324-30 | JQB | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| November 4, 1997 | K973933 | SERUM IRON-SL ASSAY, CATALOGUE NUMBERS 157-10, 157-30 | JIY | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| June 18, 1997 | K971573 | N-GENEOUS LDL CHOLESTEROL REAGENT, N-GENEOUS LDL CHOLESTEROL CALIBRATOR, GENZYME LDL CHOLESTEROL CONTROL SET | LBR | Substantially Equivalent | Genzyme Corp. | accessdata.fda.gov |
| June 16, 1997 | K971162 | LIQUID N-GENEOUS HDL CHOLESTEROL KIT/CALIBRATOR | LBS | Substantially Equivalent | Genzyme Corp. | accessdata.fda.gov |
| August 20, 1996 | K963116 | UNSATURATED IRON BINDING CAPACITY (UIBC) ASSAY | JMO | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| August 16, 1996 | K961281 | TRIGLYCERIDE-SL ASSAY CATALOGUE NO. 236-60 | CDT | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| July 23, 1996 | K961586 | URIC ACID-SL ASSAY CATALOGUE NO. 237-60 | KNK | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| June 21, 1996 | K961282 | GLUCOSE-SL ASSAY, CATALOGUE NO. 235-60 | CFR | Substantially Equivalent | Diagnostic Chemicals , Ltd. | accessdata.fda.gov |
| August 2, 1994 | K932556 | AMMONIA ASSAY CAT. NO. 200-02 | JIF | Substantially Equivalent | Diagnostic Chemicals, Ltd. (Usa) | accessdata.fda.gov |
| August 19, 1993 | K932555 | DC-LINEATE CAT. NO. SE-091 | JIS | Substantially Equivalent | Diagnostic Chemicals, Ltd. (Usa) | accessdata.fda.gov |
| February 26, 1990 | K897150 | LIPASE COLOR [TOYO] SERUM LIPASE TEST KIT | CHI | Substantially Equivalent | Toyo Jozo Co., Ltd. | accessdata.fda.gov |
| December 12, 1989 | K896073 | CHOLESTEROL, UNIVERSAL ET | CHH | Substantially Equivalent | Enzyme Technology, Inc. | accessdata.fda.gov |
| December 12, 1989 | K895873 | CALCIUM, CATALOGUE NUMBER140-20 | CJY | Substantially Equivalent | Diagnostic Chemicals, Ltd. (Usa) | accessdata.fda.gov |
| September 2, 1988 | K875285 | MULTI-CHEMISTRY LINEARITY STANDARD | JIX | Substantially Equivalent | Verichem Laboratories, Inc. | accessdata.fda.gov |
| August 30, 1988 | K882258 | DC-LIQUICAL CATALOGUE #SE-030 | JIX | Substantially Equivalent | Diagnostic Chemicals, Ltd. (Usa) | accessdata.fda.gov |
| April 18, 1988 | K875211 | GLUCOSE (TRINDER) CAT. # 220-32 | CGA | Substantially Equivalent | Diagnostic Chemicals, Ltd. (Usa) | accessdata.fda.gov |
| April 21, 1986 | K861094 | BILIRUBIN ASSAY KIT (DIRECT), CATA. NUMBER 202-02 | CIG | Substantially Equivalent | Diagnostic Chemicals, Ltd. (Usa) | accessdata.fda.gov |
| September 7, 1984 | K843104 | ALBUMIN ASSAY KIT | CIX | Substantially Equivalent | Diagnostic Chemicals, Ltd. (Usa) | accessdata.fda.gov |
| August 27, 1984 | K843028 | TOTAL PROTEIN ASSAY KIT | CEK | Substantially Equivalent | Diagnostic Chemicals, Ltd. (Usa) | accessdata.fda.gov |
| August 17, 1984 | K842160 | CHOLESTEROL ASSSAY KIT | CHH | Substantially Equivalent | Diagnostic Chemicals, Ltd. (Usa) | accessdata.fda.gov |
Recalls
Recall events where this establishment is the recalling firm, matched on its FEI.
| Initiated | Event | Class | Status | Product | Reason | Source |
|---|---|---|---|---|---|---|
| November 29, 2016 | 75818 | Class II | Terminated | Sekisui Diagnostics Ammonia L3K Assay; Catalog Number: 293-80-91 and 293-10 For the IN VITRO quantitative measurement of ammonia concentration in plasma | Certain lots are showing an atypical decrease in optical density (OD) over time, which may result in an impact to performance at the high end of the linear range. | accessdata.fda.gov |
| January 22, 2016 | 73129 | Class II | Terminated | Sekure Chemistry Sekisui Diagnostics Acetaminophen L3K Assay, In-vitro Diagnostic Catalog Number: 506-10: R1: 1 x 10ml, R2: 2 x 10ml Catalog Number: 506-30: R1: 3 x 10ml, R2: 6 x 10ml In-Vitro quantitative measurement of | Crystal formation in the Color Reagent (R2) when left on board automated analyzers causing samples to under recover | accessdata.fda.gov |
| November 10, 2010 | 57230 | Not yet classified | Terminated | Genzyme Diagnostics Total Serum Cholesterol Kit, IVD Catalog Number: 225-26 Intended use: For the IN VITRO quantitative measurement of total serum cholesterol in serum. | Cholesterol Reagent bottles labels reversed for R1 and R2 | accessdata.fda.gov |
| February 12, 2009 | 51156 | Not yet classified | Terminated | DCL (Diagnostic Chemicals Limited) Creatine Enzyme Reagent (R2) Catalog Number: 265-30. In-vitro diagnostic device used for the quantitative measurement of creatine in serum, plasma and urine. | Labeled with extended expiration date (24 months instead of 18 months) | accessdata.fda.gov |
| March 14, 2008 | 47475 | Not yet classified | Terminated | Diagnostics Chemical Limited Iron Assay Catalog Number: 102-25 For the In Vitro quantitative determination of iron in serum. | Precipitate in product may cause elevated background absorbance interference. | accessdata.fda.gov |
| December 5, 2006 | 37011 | Not yet classified | Terminated | Salicylate-SL, in vitro diagnostic, Cat. No.511-20, Lot No. 29892 | Upon subsequent testing on different instruments (as required by other customers), DCL detected a non-linear response on certain analyzers. A decision was made to recall the product due to the fact that DCL customers sell the product to different end users, DCL cannot be certain which instruments the end users employ in their laboratories | accessdata.fda.gov |
| September 6, 2006 | 36864 | Not yet classified | Terminated | Microalbumin Multi-Calibrator Set, in vitro diagnostic. Catalog Number: SE-252 | Microalbumin Multi Calibrator mislabeled label on Level 5 and Level 6, cap label correct | accessdata.fda.gov |
Compare with other makers
- All makers of Calibrator, Multi-Analyte Mixture
- All makers of Colorimetry, Salicylate
- All makers of Ldl & Vldl Precipitation, Cholesterol Via Esterase-Oxidase, Hdl
- All makers of Photometric Method, Magnesium
- All makers of Calibrator, Primary
- All makers of Ldl & Vldl Precipitation, Hdl
Updated February 18, 2022. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.